A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation
- 1 January 2014
- journal article
- clinical trial
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 7 (1), 89-99
- https://doi.org/10.1016/j.jcin.2013.07.007
Abstract
No abstract availableFunding Information
- Elixir Medical Corporation
This publication has 26 references indexed in Scilit:
- Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly- l -Lactic Acid Coronary StentsCirculation, 2012
- Late Positive Remodeling and Late Lumen Gain Contribute to Vascular Restoration by a Non-Drug Eluting Bioresorbable ScaffoldCirculation: Cardiovascular Interventions, 2012
- Bioabsorbable Coronary StentsCirculation: Cardiovascular Interventions, 2009
- Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery LesionsCirculation, 2006
- Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents: A Review of Available Cases From the Research on Adverse Drug Events and Reports (RADAR) ProjectJournal of the American College of Cardiology, 2006
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery LesionsCirculation, 2003
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationThe New England Journal of Medicine, 2002
- Arterial Remodeling After Coronary AngioplastyCirculation, 1996
- Compensatory Enlargement of Human Atherosclerotic Coronary ArteriesThe New England Journal of Medicine, 1987